Verbesserte Diagnostik von zerebralen Gliomen mit der FET PET

Positron emission tomography (PET) using radiolabeled amino acids has shown great potential for more accurate diagnostics of cerebral gliomas. O-(2-[18F]Fluoroethyl)-L-tyrosine (FET) is a new tracer for PET which can be produced with high efficiency and distributed on a wide clinical scale in Germany. In a biopsy-controlled study, a significant improvement of the detection of true tumor extent of cerebral gliomas could be demonstrated by the combined use of FET PET and MRT in comparison with MRT alone. Advantages of FET PET are an improved guidance of biopsies, an improved planning of surgery and radiation therapy, and the differentiation of tumor recurrence from unspecific post-therapeutic tissue changes. Furthermore, FET PET appears to be particularly valuable in the prognosis of low-grade gliomas.

[1]  G. Stoffels,et al.  18F-FET PET compared with 18F-FDG PET and CT in patients with head and neck cancer. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  H. Herzog,et al.  Whole-body distribution and dosimetry of O-(2-[18F]fluoroethyl)-l-tyrosine , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[3]  C. Götz,et al.  Serial O-(2-[18F]fluoroethyl)-L-tyrosine PET for monitoring the effects of intracavitary radioimmunotherapy in patients with malignant glioma , 2006, European Journal of Nuclear Medicine and Molecular Imaging.

[4]  R. Goldbrunner,et al.  O-(2-[18F]fluoroethyl)-l-tyrosine PET for monitoring the effects of convection-enhanced delivery of paclitaxel in patients with recurrent glioblastoma , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[5]  B. Weber,et al.  Uptake of 18F-fluorocholine, 18F-fluoroethyl-L-tyrosine, and 18F-FDG in acute cerebral radiation injury in the rat: implications for separation of radiation necrosis from tumor recurrence. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  M. Schwaiger,et al.  Differentiation of tumour and inflammation: characterisation of [methyl-3H]methionine (MET) and O-(2-[18F]fluoroethyl)-L-tyrosine (FET) uptake in human tumour and inflammatory cells , 2006, European Journal of Nuclear Medicine and Molecular Imaging.

[7]  G. Reifenberger,et al.  18F-FET PET differentiation of ring-enhancing brain lesions. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[8]  Karl-Josef Langen,et al.  O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas. , 2005, Brain : a journal of neurology.

[9]  C. Degueldre,et al.  Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  W. Koch,et al.  Positron Emission Tomography with O-(2-[18F]fluoroethyl)-l-tyrosine versus Magnetic Resonance Imaging in the Diagnosis of Recurrent Gliomas , 2005, Neurosurgery.

[11]  Morand Piert,et al.  Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy. , 2004, International journal of radiation oncology, biology, physics.

[12]  M. Schwaiger,et al.  Investigation of transport mechanism and uptake kinetics of O-(2-[18F]fluoroethyl)-L-tyrosine in vitro and in vivo. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  Lutz Tellmann,et al.  Comparison of O-(2-18F-fluoroethyl)-L-tyrosine PET and 3-123I-iodo-alpha-methyl-L-tyrosine SPECT in brain tumors. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  K. Zilles,et al.  Comparison of fluorotyrosines and methionine uptake in F98 rat gliomas. , 2003, Nuclear medicine and biology.

[15]  Karl-Josef Langen,et al.  O-(2-[18F]fluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications. , 2006, Nuclear medicine and biology.

[16]  M. Kurrer,et al.  18F-FDG and 18F-FET uptake in experimental soft tissue infection , 2002, European Journal of Nuclear Medicine and Molecular Imaging.

[17]  B. Weber,et al.  Uptake of 18F-fluorocholine, 18F-fluoro-ethyl-L-tyrosine and 18F-fluoro-2-deoxyglucose in F98 gliomas in the rat , 2006, European Journal of Nuclear Medicine and Molecular Imaging.

[18]  H. Engler,et al.  Positron emission tomography 11C‐methionine and survival in patients with low‐grade gliomas , 2001 .

[19]  M. Bergström,et al.  Positron Emission Tomography Compared with Magnetic Resonance Imaging and Computed Tomography in Supratentorial Gliomas Using Multiple Stereotactic Biopsies as Reference , 1989, Acta radiologica.

[20]  W. Koch,et al.  Analysis of 18F-FET PET for grading of recurrent gliomas: is evaluation of uptake kinetics superior to standard methods? , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[21]  H. Herzog,et al.  PET with O-(2-18F-Fluoroethyl)-L-Tyrosine in peripheral tumors: first clinical results. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[22]  A. Krüger,et al.  O-(2-[18F]Fluoroethyl)-L-tyrosine (FET): a tracer for differentiation of tumour from inflammation in murine lymph nodes , 2002, European Journal of Nuclear Medicine and Molecular Imaging.

[23]  Wolfgang A. Weber,et al.  O-(2-[18F]Fluoroethyl)-l-tyrosine and l-[methyl-11C]methionine uptake in brain tumours: initial results of a comparative study , 2000, European Journal of Nuclear Medicine.

[24]  K. Langen,et al.  3-[123I]Iodo-α-methyl-L-tyrosine: uptake mechanisms and clinical applications , 2002 .

[25]  Jörg-Christian Tonn,et al.  Value of O-(2-[18F]fluoroethyl)-l-tyrosine PET for the diagnosis of recurrent glioma , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[26]  M van Herk,et al.  Target volumes in radiotherapy for high-grade malignant glioma of the brain. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[27]  Hans-Jakob Steiger,et al.  Multimodal metabolic imaging of cerebral gliomas: positron emission tomography with [18F]fluoroethyl-L-tyrosine and magnetic resonance spectroscopy. , 2005, Journal of neurosurgery.

[28]  M Schwaiger,et al.  Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imaging. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[29]  K. Hamacher,et al.  Efficient routine production of the 18F-labelled amino acid O-2-18F fluoroethyl-L-tyrosine. , 2002, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[30]  K. Hamacher,et al.  O-(2-[18F]fluorethyl)-L-tyrosine PET in the clinical evaluation of primary brain tumours , 2005, European Journal of Nuclear Medicine and Molecular Imaging.